loadpatents
name:-0.021374940872192
name:-0.026705026626587
name:-0.0012569427490234
McCombie; Stuart W. Patent Filings

McCombie; Stuart W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for McCombie; Stuart W..The latest application filed is for "piperidine derivatives useful as ccr5 antagonists".

Company Profile
0.23.15
  • McCombie; Stuart W. - Caldwell NJ
  • McCombie; Stuart W. - West Orange NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Piperazine derivatives useful as CCR5 antagonists
Grant 8,114,879 - Baroudy , et al. February 14, 2
2012-02-14
Piperidinyl piperidine derivatives useful as inhibitors of chemokine receptors
Grant 7,705,019 - Chan , et al. April 27, 2
2010-04-27
Piperidinyl piperazine derivatives useful as inhibitors of chemokine receptors
Grant 7,659,275 - Chan , et al. February 9, 2
2010-02-09
Piperidine Derivatives Useful As Ccr5 Antagonists
App 20080188485 - Baroudy; Bahige M. ;   et al.
2008-08-07
Piperazine derivatives useful as CCR5 antagonists
Grant 7,384,944 - Baroudy , et al. June 10, 2
2008-06-10
Heteroaryl urea neuropeptide Y Y5 receptor antagonists
Grant 7,309,704 - Stamford , et al. December 18, 2
2007-12-18
Compounds for inhibiting KSP kinesin activity
App 20060247320 - Tagat; Jayaram R. ;   et al.
2006-11-02
Piperidinyl piperazine derivatives useful as inhibitors of chemokine receptors
App 20060223821 - Chan; Tze-Ming ;   et al.
2006-10-05
Piperidinyl piperidine derivatives useful as inhibitors of chemokine receptors
App 20060223856 - Chan; Tze-Ming ;   et al.
2006-10-05
Heteroaryl urea neuropeptide Y Y5 receptor antagonists
App 20060030588 - Stamford; Andrew ;   et al.
2006-02-09
Heteroaryl urea neuropeptide Y Y5 receptor antagonists
Grant 6,982,267 - Stamford , et al. January 3, 2
2006-01-03
Heteroaryl urea neuropeptide Y Y5 receptor antagonists
Grant 6,946,476 - Stamford , et al. September 20, 2
2005-09-20
Substituted urea neuropeptide Y Y5 Receptor antagonists
Grant 6,894,063 - Greenlee , et al. May 17, 2
2005-05-17
Substituted urea neuropeptide Y Y5 receptor antagonists
App 20050038100 - Greenlee, William J. ;   et al.
2005-02-17
Piperazine derivatives useful as CCR5 antagonists
App 20040067961 - Baroudy, Bahige M. ;   et al.
2004-04-08
Piperazine derivatives useful as CCR5 antagonists
Grant 6,689,765 - Baroudy , et al. February 10, 2
2004-02-10
Heteroaryl urea neuropeptide Y Y5 receptor antagonists
App 20040006086 - Stamford, Andrew ;   et al.
2004-01-08
Piperidine derivatives useful as CCR5 antagonists
Grant 6,602,885 - Baroudy , et al. August 5, 2
2003-08-05
Substituted urea neuropeptide Y Y5 receptor antagonists
App 20030114517 - Greenlee, William J. ;   et al.
2003-06-19
Aryl oxime-piperazines useful as CCR5 antagonists
App 20030087912 - Clader, John W. ;   et al.
2003-05-08
Piperazine derivatives useful as CCR5 antagonists
App 20030069252 - Baroudy, Bahige M. ;   et al.
2003-04-10
Heteroaryl urea neuropeptide Y Y5 receptor antagonists
App 20030055062 - Stamford, Andrew ;   et al.
2003-03-20
Piperidine derivatives useful as CCR5 antagonists
App 20030004185 - Baroudy, Bahige M. ;   et al.
2003-01-02
Substituted urea neuropeptide Y Y5 receptor antagonists
App 20020165223 - Greenlee, William J. ;   et al.
2002-11-07
Muscarinic antagonists
App 20020103205 - Lowe, Derek ;   et al.
2002-08-01
Piperazine derivatives useful as CCR5 antagonists
Grant 6,391,865 - Baroudy , et al. May 21, 2
2002-05-21
Piperidine derivatives useful as CCR5 antagonists
Grant 6,387,930 - Baroudy , et al. May 14, 2
2002-05-14
Muscarinic antagonists
Grant 6,294,554 - Clader , et al. September 25, 2
2001-09-25
Muscarinic antagonists
Grant 6,066,636 - Kozlowski , et al. May 23, 2
2000-05-23
Muscarinic antagonists
Grant 6,043,255 - Lowe , et al. March 28, 2
2000-03-28
Muscarinic antagonists
Grant 6,037,352 - Lowe , et al. March 14, 2
2000-03-14
Muscarinic antagonists
Grant 5,889,006 - Lowe , et al. March 30, 1
1999-03-30
Muscarinic antagonists
Grant 5,883,096 - Lowe , et al. March 16, 1
1999-03-16
3-substituted-1-aryl-2(H)-quinolones and their pharmaceutical compositions
Grant 5,064,837 - McCombie November 12, 1
1991-11-12
Intermediate compounds for preparing penems and carbapenems
Grant 4,876,365 - Kirkup , et al. October 24, 1
1989-10-24
Intermediates for preparation of (threo)-1-aryl-2-acylamido-3-fluoro-1-propanols
Grant 4,677,214 - Nagabhushan , et al. June 30, 1
1987-06-30
Deprotection of allylic esters, carbonates and carbamates catalyzed by palladium compounds
Grant 4,314,942 - McCombie February 9, 1
1982-02-09
Process for deoxygenating secondary alcohols
Grant 4,078,139 - Barton , et al. March 7, 1
1978-03-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed